Krystal Biotech, Inc. (KRYS)
341.78
-4.80
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
341.78
0.00 (0.00%)
After-Hours: 19:20
Krystal Biotech Price to Book Value : 7.442 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 7.547 |
| August 20, 2026 | 7.339 |
| August 19, 2026 | 7.476 |
| August 18, 2026 | 7.247 |
| August 17, 2026 | 7.311 |
| August 14, 2026 | 7.235 |
| August 13, 2026 | 7.150 |
| August 12, 2026 | 7.248 |
| August 11, 2026 | 7.122 |
| August 10, 2026 | 7.221 |
| August 07, 2026 | 7.109 |
| August 06, 2026 | 7.027 |
| August 05, 2026 | 7.094 |
| August 04, 2026 | 7.072 |
| August 03, 2026 | 6.806 |
| July 31, 2026 | 7.428 |
| July 30, 2026 | 7.988 |
| July 29, 2026 | 7.911 |
| July 28, 2026 | 7.931 |
| July 27, 2026 | 7.661 |
| July 24, 2026 | 7.299 |
| July 23, 2026 | 7.132 |
| July 22, 2026 | 7.334 |
| July 21, 2026 | 7.383 |
| July 20, 2026 | 7.387 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.727 |
| July 16, 2026 | 7.443 |
| July 15, 2026 | 7.627 |
| July 14, 2026 | 7.391 |
| July 13, 2026 | 7.914 |
| July 10, 2026 | 7.966 |
| July 09, 2026 | 8.084 |
| July 08, 2026 | 8.175 |
| July 07, 2026 | 8.026 |
| July 06, 2026 | 8.159 |
| July 02, 2026 | 8.167 |
| July 01, 2026 | 8.091 |
| June 30, 2026 | 8.093 |
| June 29, 2026 | 8.719 |
| June 26, 2026 | 8.583 |
| June 25, 2026 | 8.299 |
| June 24, 2026 | 8.015 |
| June 23, 2026 | 7.844 |
| June 22, 2026 | 7.918 |
| June 18, 2026 | 8.025 |
| June 17, 2026 | 7.878 |
| June 16, 2026 | 7.456 |
| June 15, 2026 | 7.488 |
| June 12, 2026 | 7.331 |
| June 11, 2026 | 7.414 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Marker Therapeutics, Inc. | 2.056 |
| TG Therapeutics, Inc. | 14.20 |
| Tenaya Therapeutics, Inc. | 2.160 |
| Cytokinetics, Inc. | -- |
| Vericel Corp. | 5.857 |
Price to Book Value Related Metrics
| PE Ratio | 42.83 |
| PS Ratio | 23.52 |
| PEG Ratio | 0.6872 |
| Price to Free Cash Flow | 40.19 |
| Price | 341.78 |
| Earnings Yield | 2.33% |
| Market Cap | 10.12B |
| PEGY Ratio | 0.6872 |
| Operating PE Ratio | 52.39 |
| Normalized PE Ratio | 42.83 |